The specificity of PSA testing was found to be limited and, if combined with liberal criteria for performing a biopsy, may lead to unnecessary treatment with side-effects seriously limiting a patient’s life quality, as a consequence of impotence, urinary leakage and bowel dysfunction [38]. The gene discussed is KLK3; the disease is bowel dysfunction.